Massively has the latest Warhammer Online news, guides and analysis!

AOL Money & Finance

Early analyst calls (GM) (XOM)

Citi Investment Research maintained its "hold" rating on Biogen Idec (NASDAQ:BIIB) saying the firm "is poised to gain from higher prices for multiple sclerosis drugs," according to the AP.

Merrill Lynch downgraded GM (NYSE:GM) to "underperform" from "buy", according to Briefing.com. Bernstein upgraded Exxon Mobil (NYSE:XOM) to "outperform" from "market perform", the news service also reported.

Douglas A. McIntyre is an editor at 247wallst.com.

Related Posts

Reader Comments (Page 1 of 1)

Symbol Lookup
IndexesChangePrice

Last updated: October 11, 2008: 01:51 AM

BloggingStocks Exclusives

Hot Stocks

BloggingStocks Featured Video

TheFlyOnTheWall.com Headlines

WalletPop Headlines

AOL Business News

Latest from BloggingBuyouts

Sponsored Links

My Portfolios

Track your stocks here!

Find out why more people track their portfolios on AOL Money & Finance then anywhere else.

BloggingStocks Partners

More from AOL Money & Finance